Pharmacophore models for subtype-selective analogs of somatostatin (SRIF) based on NMR structures

被引：0
|
作者：
Grace, Christy R. R. [1 ]
Koerber, Steven C. [1 ]
Erchegyi, Judit [1 ]
Durrer, Lukas [1 ]
Reubi, Jean Claude [1 ]
Rivier, Jean [1 ]
Riek, Roland [1 ]
机构：
[1] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA
来源：
Peptides 2004, Proceedings: BRIDGES BETWEEN DISCIPLINES | 2005年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：726 / 727
页数：2
相关论文
共 50 条
  • [41] Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells - A quantitative double-label immunohistochemical analysis
    Kumar, U
    Sasi, R
    Suresh, S
    Patel, A
    Thangaraju, M
    Metrakos, P
    Patel, SC
    Patel, YC
    DIABETES, 1999, 48 (01) : 77 - 85
  • [42] Erratum to: Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    Jean Reubi
    Beatrice Waser
    Jean-Claude Schaer
    Jean A. Laissue
    European Journal of Nuclear Medicine, 2001, 28 (9) : 1433 - 1433
  • [43] HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain
    Di Lio, Alessandra
    Benke, Dietmar
    Besson, Marie
    Desmeules, Jules
    Daali, Youssef
    Wang, Zhi-jian
    Edwankar, Rahul
    Cook, James M.
    Zeilhofer, Hanns Ulrich
    NEUROPHARMACOLOGY, 2011, 60 (04) : 626 - 632
  • [44] Novel lipoamino acid and liposaccharide based peptide delivery system for tumor selective somatostatin analogs
    Malkinson, JP
    Keri, G
    Artursson, P
    Toth, I
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 779 - 781
  • [45] Receptor based design, synthesis and biological activity of highly potent and selective somatostatin analogs.
    Igarashi, J
    Jiang, XH
    Li, HT
    Goodman, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U297 - U297
  • [46] Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas - Novel potential therapy for functional pituitary tumors
    Shimon, I
    Yan, XM
    Taylor, JE
    Weiss, MH
    Culler, MD
    Melmed, S
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09): : 2386 - 2392
  • [47] Selective Pharmacophore Models of Dopamine D1 and D2 Full Agonists Based on Extended Pharmacophore Features
    Malo, Marcus
    Brive, Lars
    Luthman, Kristina
    Svensson, Peder
    CHEMMEDCHEM, 2010, 5 (02) : 232 - 246
  • [48] Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands:: Potent, TRβ subtype-selective thyromimetics
    Dow, RL
    Schneider, SR
    Paight, ES
    Hank, RF
    Chiang, P
    Cornelius, P
    Lee, E
    Newsome, WP
    Swick, AG
    Spitzer, J
    Hargrove, DM
    Patterson, TA
    Pandit, J
    Chrunyk, BA
    LeMotte, PK
    Danley, DE
    Rosner, MH
    Ammirati, MJ
    Simons, SP
    Schulte, GK
    Tate, BF
    DaSilva-Jardine, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 379 - 382
  • [49] GPCR Somatostatin Receptor Extracellular Loop 2 Is a Key Ectodomain for Making Subtype-Selective Antibodies With Agonist-Like Activities in the Pancreatic Neuroendocrine Tumor BON Cell Line
    Leu, Frank P.
    Nandi, Minesh
    PANCREAS, 2010, 39 (08) : 1155 - 1166
  • [50] Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands (vol 28, pg 1433, 2001)
    Rebui, JC
    Waser, B
    Schaer, JC
    Laissue, JA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09): : 1433 - 1433
12345